Candidate selection for heart transplantation in the 21st century

Current Opinion in Organ Transplantation

Volumn 7, Issue 3, 2002, Pages 221-225

  Lim, Eric ^a   Large, Stephen ^a   Wallwork, John ^a   Parameshwar, Jayan ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; SPIRONOLACTONE;

ARTICLE; CONTROLLED STUDY; DEVELOPED COUNTRY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; PATIENT SELECTION; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT;

EID: 0036743049     PISSN: 10872418     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075200-200209000-00002     Document Type: Article

References (51)

1. Cowie MR, Mosterd A, Wood DA, et al.: The epidemiology of heart failure. Eur Heart J 1997, 18:208-225.
2. Copeland JG: Advanced medical therapy does not render heart transplantation obsolete for ambulatory end-stage heart failure patients: a debate. J Heart Lung Transplant 2001, 20:725-728.
3. Hosenpud JD, Bennett LE, Keck BM, et al.: The Registry of the International Society for Heart and Lung Transplantation: eighteenth Official Report-2001. J Heart Lung Transplant 2001, 20:805-815.
4. Packer M, Coats AJS, Fowler MB, et al.: Effect of Carvedilol on Survival in Severe Chronic Heart Failure. N Engl J Med 2001, 344:1651-1658.
5. The Beta-Blocker Evaluation of Survival Trial Investigators: A trial of the β-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 2001, 344:1659-1667.
6. Brophy JM, Joseph L, Rouleau JL: Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med 2001, 134:550-560.
7. Flather MD, Yusuf S, Kober L, et al.: Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-inhibitor Myocardial Infarction Collaborative Group. Lancet 2000, 355:1575-1581.
8. Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 341:709-717.
9. Weber KT: Aldosterone in congestive heart failure. N Engl J Med 2001, 345:1689-1697.
10. Task Force of the Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 1997, 18:736-753.
11. Hunt SA, Baker DW, Chin MH, et al.: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001, 38:2101-2113.
12. Philbin EF, Rocco TA, Jr., Lindenmuth NW, et al.: Clinical outcomes in heart failure: report from a community hospital-based registry. Am J Med 1999, 107:549-555.
13. Rickenbacher PR, Trindade PT, Haywood GA, et al.: Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival. J Am Coll Cardiol 1996, 27:1192-1197.
14. Alderman EL, Fisher LD, Litwin P, et al.: Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983, 68:785-795.
15. Killip T, Passamani E, Davis K: Coronary artery surgery study (CASS): a randomized trial of coronary bypass surgery. Eight years follow-up and survival in patients with reduced ejection fraction. Circulation 1985, 72:V102-V109.
16. Hausmann H, Topp H, Siniawski H, et al.: Decision-making in end-stage coronary artery disease: revascularization or heart transplantation? Ann Thorac Sung 1997, 64:1296-1301; discussion 1302.
17. Di Carli MF, Maddahi J, Rokhsar S, et al.: Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg 1998, 116:997-1004.
18. Mickleborough LL, Carson S, Tamariz M, et al.: Results of revascularization in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg 2000, 119:550-557.
19. Lorusso R, La Canna G, Ceconi C, et al.: Long-term results of coronary artery bypass grafting procedure in the presence of left ventricular dysfunction and hibernating myocardium. Eur J Cardiothorac Surg 2001, 20:937-948.
20. Bouchart F, Tabley A, Litzler PY, et al.: Myocardial revascularization in patients with severe ischemic left ventricular dysfunction. Long term follow-up in 141 patients. Eur J Cardiothorac Surg 2001, 20:1157-1162.
21. Pagano D, Lewis ME, Townend JN, et al.: Coronary revascularization for postischaemic heart failure: how myocardial viability affects survival. Heart 1999, 82:684-688.
22. Bax JJ, Poldermans D, Elhendy A, et al.: Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999, 34:163-169.
23. Johnson MR, Costanzo-Nordin MR, Heroux AL, et al.: High-risk cardiac operation: a viable alternative to heart transplantation. Ann Thorac Surg 1993, 55:876-882.
24. Bishay ES, McCarthy PM, Cosgrove DM, et al.: Mitral valve surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg 2000, 17:213-221.
25. Cope JT, Kaza AK, Reade CC, et al.: A cost comparison of heart transplantation versus alternative operations for cardiomyopathy. Ann Thorac Surg 2001, 72:1298-1305.
26. Franco-Cereceda A, McCarthy PM, Blackstone EH, et al.: Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation? J Thorac Cardiovasc Surg 2001, 121:879-893.
27. Bolling SF: Mitral valve reconstruction in the patient with heart failure. Heart Fail Rev 2001, 6:177-185.
28. Cowie MR, Wood DA, Coats AJ, et al.: Survival of patients with a new diagnosis of heart failure: a population based study. Heart 20OO, 83:505-510.
29. Deng MC, De Meester JM, Smits JM, et al.: Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group. BMJ 2000, 321:540-545.
30. Mancini D, LeJemtel T, Aaronson K: Peak VO(2):a simple yet enduring standard. Circulation 2000, 101:1080-1082.
31. Stevenson LW, Miller LW: Cardiac transplantation as therapy for heart failure. Curr Probl Cardiol 1991, 16:217-305.
32. Cicoira M, Davos CH, Florea V, et al.: Chronic heart failure in the very elderly: clinical status, survival, and prognostic factors in 188 patients more than 70 years old. Am Heart J 2001, 142:174-180.
33. Aaronson KD, Schwartz JS, Chen TM, et al.: Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997, 95:2660-2667.
34. Erickson KW, Costanzo-Nordin MR, O'Sullivan EJ, et al.: Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant 1990, 9:526-537.
35. Stobierska-Dzierzek B, Awad H, Michler RE: The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 2001, 38:923-931.
36. Chen J, Levin H, Michler R, et al.: Reevaluating the significance of pulmonary hypertension before cardiac transplantation: Determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. Journal of Thoracic and Cardiovascular Surgery 1997, 114:627-634.
37. Delgado JF, Gomez-Sanchez MA, Saenz de la Calzada C, et al.: Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. J Heart Lung Transplant 2001, 20:942-948.
38. Hutter JA, Scott JP, Deespins P, et al.: Heart-lung transplantation at Papworth Hospital. Eur J Cardiothorac Surg 1989, 3:300-303; discussion 303-304.
39. Dubrey SW, Burke MM, Khaghani A, et al.: Long term results of heart transplantation in patients with amyloid heart disease. Heart 2001, 85:202-207.
40. Aleksic I, Czer LS, Freimark D, et al.: Heart transplantation in patients with diabetic end-organ damage before transplantation. Thorac Cardiovasc Surg 1996, 44:282-288.
41. Lietz K, John R, Burke EA, et al.: Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation 2001, 72:277-283.
42. Grady KL, White-Williams C, Naftel D, et al.: Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group. J Heart Lung Transplant 1999,18:750-763.
43. Brann WM, Bennett LE, Keck BM, et al.: Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. J Heart Lung Transplant 1998, 17:374-382.
44. Shane E, Papadopoulos A, Staron RB, et al.: Bone loss and fracture after lung transplantation. Transplantation 1999, 68:220-227.
45. Blanche C, Blanche D, Kearney B, et al.: Heart transplantation in patients seventy years of age and older: A comparative analysis of outcome. Journal of Thoracic and Cardiovascular Surgery 2001, 121:532-541.
46. Borkon AM, Muehlebach GF, Jones PG, et al.: An analysis of the effect of age on survival after heart transplant. J Heart Lung Transplant 1999, 18:668-674.
47. Narula J, Bennett LE, DiSalvo T, et al.: Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry. Transplantation 1997, 63:861-867.
48. Blanche C, Kamlot A, Blanche DA, et al.: Combined heart-kidney transplantation with single-donor allografts. J Thorac Cardiovasc Surg 2001, 122:495-500.
49. Rose EA, Gelijns AC, Moskowitz AJ, et al.: Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001, 345:1435-1443.
50. SoRelle R: Cardiovascular news. Totally contained AbioCor artificial heart implanted July 3, 2001. Circulation 2001, 104:E9005-E9006.
51. Menasche P, Hagege AA, Scorsin M, et al.: Myoblast transplantation for heart failure. Lancet 2001, 357:279-280.